Literature DB >> 1832866

Signal transduction in T cells.

C H June1.   

Abstract

Rapid progress was made during the past year in the delineation of the nature of the initial biochemical events triggered by the T-cell antigen receptor. Antigen-mediated activation of phospholipase C was demonstrated to require protein tyrosine phosphorylation and, most surprising, activation of the Ras family of signal transduction molecules was shown to closely follow stimulation of the T-cell antigen receptor. Major controversy continues over which events are relevant to the various effector functions of T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832866     DOI: 10.1016/0952-7915(91)90026-w

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

1.  Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).

Authors:  C L Jellis; S S Wang; P Rennert; F Borriello; A H Sharpe; N R Green; G S Gray
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 2.  Accessory cell-derived signals required for T cell activation.

Authors:  J G Johnson; M K Jenkins
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 3.  Relevance of the T cell receptor for immunotherapy of cancer.

Authors:  E Weidmann; M Trucco; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

4.  Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).

Authors:  A Katzav; Y Kloog; A D Korczyn; H Niv; D M Karussis; N Wang; R Rabinowitz; M Blank; Y Shoenfeld; J Chapman
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.

Authors:  R A Franklin; A Tordai; H Patel; A M Gardner; G L Johnson; E W Gelfand
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Authors:  C Giordano; R De Maria; M Todaro; G Stassi; A Mattina; P Richiusa; G Galluzzo; F Pantó; A Galluzzo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.